<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>HOMATROPINE- homatropine hydrobromide solution/ drops </strong><br>HUB Pharmaceuticals<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1><span class="Bold"><span class="Bold">Homatropine Hydrobromide 5% Ophthalmic Solution USP (Sterile) Rx Only</span></span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
<h1></h1>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1><span class="Bold">DESCRIPTION:</span></h1>
<p class="First"><span class="Bold">Homatropine Hydrobromide </span>ophthalmic solution is a sterile solution for ophthalmic administration in drop form, having the following composition:</p>
<p>Plastic squeeze bottle</p>
<p><span class="Bold">Homatropine Hydrobromide </span>20-50 mg/mL (cycloplegic-mydriatic) in a buffered aqueous solution containing boric acid, potassium chloride, edetate disodium and water for injection, preserved with benzalkonium chloride. The chemical name is 1αH, 3αH-Tropan-3α-o1mandelate (ester) hydrobromide. It has the following chemical structure:</p>
<p><img alt="HUB_Homatropine Hydrobromide_Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7d64b0e4-10c3-44b6-ac95-ededde5fda71&amp;name=HUB_Homatropine%20Hydrobromide_Formula.jpg"></p>
</div>
<div class="Section" data-sectionCode="51727-6">
<a name="L830f0569-1a2c-41e7-99be-57a9dacf04d9"></a><a name="section-2"></a><p></p>
<h1><span class="Bold">INACTIVE INGREDIENTS:</span></h1>
<p class="First">Boric Acid, Potassium Chloride, Edetate Disodium, and Water for Injection USP.</p>
<p>Preservative: Benzalkonium Chloride USP 0.01% v/v</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="L36520691-e0f9-491f-98d8-a54f15508a42"></a><a name="section-3"></a><p></p>
<h1><span class="Bold">CLINICAL PHAMACOLOGY:</span></h1>
<p class="First"><span class="Bold">Homatropine Hydrobromide </span>causes wide dilation of the pupil and <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">paralysis</span> of accommodation. Dilation is more rapid than with atropine but <span class="product-label-link" type="condition" conceptid="375263" conceptname="Cycloplegia">cycloplegia</span> is not as pronounced and does not last as long.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="L07654c1c-8009-4e84-9ed9-1182d1299713"></a><a name="section-4"></a><p></p>
<h1><span class="Bold">INDICATIONS AND USAGE:</span></h1>
<p class="First"><span class="Bold">Homatropine Hydrobromide </span>is indicated for treatment of <span class="product-label-link" type="condition" conceptid="4274964" conceptname="Iritis">iritis</span> and <span class="product-label-link" type="condition" conceptid="434926" conceptname="Iridocyclitis">iridocyclitis</span>, for relief of <span class="product-label-link" type="condition" conceptid="434344" conceptname="Ciliary muscle spasm">ciliary spasm</span>, and also as an aid in refraction. It is frequently employed as a cycloplegic and mydriatic in preoperative and postoperative conditions.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="L0e793101-b1c8-4cde-ac52-53db1b2f0ad6"></a><a name="section-5"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS:</span></h1>
<p class="First">Contraindicated in the presence of an anatomically narrow angle or in individuals with primary <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span> and in individuals hypersensitive to one or more of the components of this preparation including the belladonna alkaloid group.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="Le7e46476-6f07-4e58-818f-5faf650365c7"></a><a name="section-6"></a><p></p>
<h1><span class="Bold">WARNINGS:</span></h1>
<p class="First">In infants and pediatric patients use with extreme caution. Excessive use in pediatric patients or certain individuals with a history of susceptibility to belladonna alkaloids may produce systemic symptoms of homatropine <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">poisoning</span> (see overdosage section).</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="Ldf0161ff-cdbe-4d66-9148-865a6525c174"></a><a name="section-7"></a><p></p>
<h1><span class="Bold">PRECAUTIONS:</span></h1>
<p class="First">Caution should be exercised when driving with <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">dilated pupils</span> or when engaging in hazardous activities. Parents of children should be cautious not to get the drug into the child’s mouth and to wash both the child’s and their hands after use of the drug.</p>
<p>If <span class="product-label-link" type="condition" conceptid="379031" conceptname="Pain in eye">eye pain</span> occurs from use of this medication, the patient should be advised to discontinue use and see prescribing physician immediately as this may indicate undiagnosed <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>. Use cautiously in elderly or hypertensive patients.</p>
<p>To avoid excessive systemic absorption, the lacrimal sac should be compressed by digital pressure for one minute after instillation.</p>
<p>Not for internal use. To prevent contaminating the dropper tip and solution, care should be taken not to touch the eyelids or surrounding area with the dropper tip of the bottle.</p>
<div class="Section" data-sectionCode="34083-6">
<a name="L773cd056-ae5b-41a6-82bd-3fe39e32bd2d"></a><a name="section-7.1"></a><p></p>
<h2><span class="Bold">Carcinogenesis, Mutagenesis, Impairment of Fertility:</span></h2>
<p class="First">There have been no long-term studies using homatropine in animals to evaluate carcinogenic potential.</p>
<div class="Section" data-sectionCode="42228-7">
<a name="L868a9b6f-2965-4fbb-8e5d-6d2b33d060b1"></a><a name="section-7.1.1"></a><p></p>
<h3>
<span class="Bold">Pregnancy</span>:</h3>
<p class="First">Pregnancy Category C. Animal reproduction studies have not been done with homatropine. It is also not known whether homatropine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Homatropine should be given to a pregnant woman only if clearly needed.</p>
<div class="Section" data-sectionCode="34080-2">
<a name="Lfb62de4a-f29d-4989-9db2-92c7db1f0be4"></a><a name="section-7.1.1.1"></a><p></p>
<h4><span class="Bold">Nursing Mothers:</span></h4>
<p class="First">Since homatropine is absorbed systemically and since it is detectable in very small amounts in human milk, and because of the potential for serious adverse reactions in nursing infants from homatropine, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p>
</div>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="Lf4840696-fcca-40b3-bfaa-bca34db09958"></a><a name="section-8"></a><p></p>
<h1>
<span class="Bold">PEDIATRIC USE</span>:</h1>
<p class="First">Homatropine should not be used during the first three months of life due to a possible association between the <span class="product-label-link" type="condition" conceptid="375263" conceptname="Cycloplegia">cycloplegia</span> produced and the development of the <span class="product-label-link" type="condition" conceptid="376981" conceptname="Amblyopia">amblyopia</span>.</p>
<p>Safety and effectiveness in pediatric patients have not been established.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="L23eff6b9-77a8-4ef9-9262-48d1f67d1106"></a><a name="section-9"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS:</span></h1>
<p class="First">Prolonged use may produce local irritation characterized by <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">follicular conjunctivitis</span>, vascular congestion, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, exudate, and eczematoid <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span>. Systemic homatropine toxicity is manifested by <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span> and dryness of the skin (a <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span> may be present in children), dryness of the mouth, <span class="product-label-link" type="condition" conceptid="140490" conceptname="Anhidrosis">anhidrosis</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, <span class="product-label-link" type="condition" conceptid="4260194" conceptname="Photophobia">photophobia</span>, loss of neuromuscular coordination (<span class="product-label-link" type="condition" conceptid="437584" conceptname="Ataxia">ataxic gait</span>), a rapid and <span class="product-label-link" type="condition" conceptid="4088122" conceptname="Heart irregular">irregular pulse</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, abdominal and bladder <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span>, dysarthric quality of speech, and mental aberration (hallucinosis) with recovery frequently followed by <span class="product-label-link" type="condition" conceptid="4198081" conceptname="Retrograde amnesia">retrograde amnesia</span>.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="Lb009f147-ddf3-4b14-a97a-0068e5f9a4f4"></a><a name="section-10"></a><p></p>
<h1><span class="Bold">OVERDOSAGE:</span></h1>
<p class="First">When signs and symptoms of homatropine toxicity develop (see adverse reactions section), physostigmine should be administered parenterally (for dosage refer to Goodman &amp; Gilman or other pharmacology reference). In infants and pediatric patients, the body surface must be kept moist.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="L75d1ae57-fd49-481b-a5b6-6c8dc5c4eb47"></a><a name="section-11"></a><p></p>
<h1><span class="Bold">DOSAGE AND ADMINISTRATION:</span></h1>
<p class="First">Usual dosage is one or two drops of the 2% or 5% solution in the eye(s) two or three times a day, modified at discretion of physician.</p>
<p>For refraction: One or two drops of the 2% solution every 10-15 minutes for 5 doses or one or two drops of the 5% solution repeated in 15 minutes, modified at discretion of the physician.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="L2f909fa9-2e98-4cb6-b47e-a6fcff691c3e"></a><a name="section-12"></a><p></p>
<p class="First">KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.</p>
</div>
<div class="Section" data-sectionCode="54433-8">
<a name="Lce36fe26-9eb3-4d55-8127-3ad49389ef8d"></a><a name="section-13"></a><p></p>
<p class="First">DO NOT USE IF IMPRINTED SEAL ON CAP IS TORN, BROKEN, OR MISSING.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="L1524ee9e-5e37-402f-af2f-cf1a25c7e048"></a><a name="section-14"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED:</span></h1>
<p class="First">5% solution: 5 mL plastic dropper tip squeeze bottle.</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="Lecd8db50-701a-4bab-b6f7-cf3b1c979946"></a><a name="section-15"></a><p></p>
<p class="First"><span class="Bold">KEEP BOTTLE TIGHTLY CLOSED WHEN NOT IN USE. </span>﻿<span class="Bold">PROTECT FROM LIGHT.</span></p>
<p><span class="Bold">STORE AT CONTROLLED ROOM TEMPERATURE </span>15°-30°C (59°-86°F).</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="L1056be2c-a4ca-444c-bf2e-2a0d3d146728"></a><a name="section-16"></a><p></p>
<p class="First">Manufactured for: <span class="Bold">HUB Pharmaceuticals, LLC</span></p>
<p>Rancho Cucamonga, CA 91730</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="L5ebda98d-78d3-4011-815a-8754bcb5472f"></a><a name="section-17"></a><p></p>
<h1><span class="Bold">REPRESENTATIVE PACKAGING:</span></h1>
<p class="First"><span class="Bold"><img alt="HUB_Homatropine Box" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7d64b0e4-10c3-44b6-ac95-ededde5fda71&amp;name=HUB_Homatropine%20Box.jpg"></span></p>
<p><span class="Bold">Image for Box</span></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>HOMATROPINE 		
					</strong><br><span class="contentTableReg">homatropine hydrobromide solution/ drops</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:17238-192</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>HOMATROPINE HYDROBROMIDE</strong> (HOMATROPINE) </td>
<td class="formItem">HOMATROPINE HYDROBROMIDE</td>
<td class="formItem">50 mg  in 5 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BORIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POTASSIUM CHLORIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>EDETATE DISODIUM</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZALKONIUM CHLORIDE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:17238-192-05</td>
<td class="formItem">1  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:17238-192-55</td>
<td class="formItem">5 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">06/10/2012</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>HUB Pharmaceuticals
							(611747945)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Conta Care Ophthalmics and Diagnostics</td>
<td class="formItem"></td>
<td class="formItem">915821765</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 6/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>127a06af-170d-4fbf-82e9-d553fe667ae4</div>
<div>Set id: 7d64b0e4-10c3-44b6-ac95-ededde5fda71</div>
<div>Version: 1</div>
<div>Effective Time: 20120610</div>
</div>
</div> <div class="DistributorName">HUB Pharmaceuticals</div></p>
</body></html>
